Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.

Get TEVA alerts

About Mark Sabag

The proxy statement of Teva Pharmaceutical Industries Ltd reports total compensation of $3,729,134 for Mark Sabag in fiscal 2023, including a base salary of $688,147. Disclosed compensation is on record for 3 fiscal years. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 6 others.

Affiliation history

Company network

Leadership on record at Teva Pharmaceutical Industries Ltd

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Teva Pharmaceutical Industries Ltd (TEVA) $688,147 $3,729,134
2022 Teva Pharmaceutical Industries Ltd (TEVA) $744,787 $3,923,933
2021 Teva Pharmaceutical Industries Ltd (TEVA) $765,294 $3,788,741

Recent activity

No call appearances or filed executive changes recorded yet.